Skip to main content
SkinCited

Vitamin A (Retinol) for Keratosis Pilaris

D

Vitamin A supports normal keratinocyte differentiation. Deficiency exacerbates KP. Topical retinoids have some evidence; oral vitamin A for KP has minimal data.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'skincited.com'; const params = 'ingredient\u003Dvitamin\u002Da\u002Dretinol\u0026condition\u003Dkeratosis\u002Dpilaris'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

D

The Bottom Line

Vitamin A supports normal keratinocyte differentiation. Deficiency exacerbates KP. Topical retinoids have some evidence; oral vitamin A for KP has minimal data.

Key Statistics

2

Studies

100

Participants

Positive

D

Grade

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

general:
700-900 mcg RAE/day (RDA)
skinhealth:
700-900 mcg RAE/day (do not exceed UL)

Upper limit: 3,000 mcg RAE/day (10,000 IU preformed vitamin A) — teratogenic at high doses

Best taken: With meals containing fat

Safety & Side Effects

Reported Side Effects

  • Headache and nausea at high doses
  • Skin dryness and peeling (hypervitaminosis A)
  • Liver toxicity with chronic excess
  • Birth defects (teratogenic — pregnancy contraindication)

Known Interactions

  • Retinoid medications (additive toxicity risk — do not combine)
  • Tetracycline antibiotics (increased intracranial pressure risk)
  • Anticoagulants (high-dose vitamin A may increase bleeding risk)
  • Hepatotoxic drugs (additive liver stress)

Tolerable upper intake: 3,000 mcg RAE/day (10,000 IU preformed vitamin A) — teratogenic at high doses

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does Vitamin A (Retinol) help with Keratosis Pilaris?
Based on 2 studies with 100 participants, there is preliminary evidence that needs more research that Vitamin A (Retinol) may support Keratosis Pilaris management. Our evidence grade is D (Very Early Research).
How much Vitamin A (Retinol) should I take for Keratosis Pilaris?
Studies have used various dosages. A commonly studied range is 700-900 mcg RAE/day (RDA). Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin A (Retinol)?
Reported side effects may include Headache and nausea at high doses, Skin dryness and peeling (hypervitaminosis A), Liver toxicity with chronic excess, Birth defects (teratogenic — pregnancy contraindication). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin A (Retinol) and Keratosis Pilaris?
We rate the evidence as Grade D (Very Early Research). This rating is based on 2 peer-reviewed studies with 100 total participants. The overall direction of effect is positive.

Related Evidence

Vitamin A (Retinol) for other conditions

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.